| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.64B | 32.10B | 32.70B | 32.86B | 33.10B | 32.36B |
| Gross Profit | 5.61B | 5.33B | 5.45B | 5.32B | 4.42B | 5.88B |
| EBITDA | 1.60B | 1.33B | 1.56B | 1.31B | 532.00M | 1.97B |
| Net Income | 548.00M | 598.00M | 522.00M | 220.00M | -444.00M | 811.00M |
Balance Sheet | ||||||
| Total Assets | 37.81B | 40.34B | 37.52B | 40.11B | 38.55B | 40.09B |
| Cash, Cash Equivalents and Short-Term Investments | 3.05B | 5.68B | 2.94B | 3.82B | 2.96B | 3.50B |
| Total Debt | 6.17B | 7.27B | 7.29B | 7.59B | 10.16B | 9.96B |
| Total Liabilities | 18.07B | 19.35B | 18.52B | 21.64B | 21.60B | 23.08B |
| Stockholders Equity | 18.54B | 19.74B | 17.79B | 17.29B | 15.87B | 15.94B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.32B | -889.00M | 2.80B | -593.00M | -705.00M |
| Operating Cash Flow | 0.00 | 1.64B | -224.00M | 3.58B | 104.00M | 1.08B |
| Investing Cash Flow | 0.00 | 501.00M | -174.00M | -60.00M | -659.00M | -1.60B |
| Financing Cash Flow | 0.00 | -64.00M | -513.00M | -2.60B | -3.00M | 861.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥92.73B | 11.05 | ― | 3.02% | 0.51% | 3.23% | |
73 Outperform | ¥77.09B | 9.11 | ― | 3.04% | -0.37% | -20.95% | |
72 Outperform | ¥35.09B | 10.77 | ― | 1.90% | -0.76% | 25.33% | |
64 Neutral | ¥27.00B | 11.36 | ― | 4.27% | 2.37% | -16.75% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
53 Neutral | ¥7.20B | 12.53 | ― | 1.35% | -1.83% | 14.37% | |
52 Neutral | ¥35.55B | 20.68 | ― | 3.70% | 29.30% | -82.16% |